LivingGLP1
Study S002692

Evaluation of Serum Estradiol Levels According to Body Mass Index Categories in Premenopausal Patients With Hormone Receptor-Positive Breast Cancer Receiving Aromatase Inhibitors and Pharmacologic Ovarian Suppression

Registration

Registration
NCT07833501
Acronym
SIMPEC-E2
Study type
OBSERVATIONAL
Status
NOT_YET_RECRUITING
Enrollment
172
Start
2026-09-03
Primary completion
2026-12-30
Lead sponsor
D'Or Institute for Research and Education
Conditions
Hormone Receptor-Positive Breast Cancer
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Percentage of Participants With Inadequate Estrogen Suppression [At 3 months of treatment (visit window: ±14 days)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.